Elephas develops an imaging platform that utilizes multimodal microscopy and artificial intelligence to assess tumor microenvironments and predict patient responses to immunotherapy. This technology provides oncologists with critical data through a secure, cloud-based portal, enhancing clinical decision-making in cancer treatment.
Funding
$120.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
SOVIFounders
Product
Problem
Current methods for predicting patient response to immunotherapy in solid tumors are unreliable, with traditional "omics" solutions failing to capture the biological complexity of live tumor tissue. This leads to a low response rate to immunotherapy, with only approximately 20% of patients benefiting from the treatment.
Solution
Elephas Biosciences offers the Elephas Live™ platform, an advanced imaging solution designed to predict individual patient response to immunotherapy. The platform utilizes fresh tumor biopsies to preserve the tumor microenvironment and assess its viability, tumor content, and reaction to immunotherapy over time. Advanced multimodal microscopy captures data at multiple time points, enabling response prediction within 72 hours of biopsy, before treatment initiation. The resulting data is aggregated and analyzed through a secure, cloud-based portal, providing oncologists with essential information to guide therapy selection.
Target Audience
The primary target audience includes oncologists and pathology labs seeking to improve immunotherapy response rates in patients with solid tumors.
Features
- Proprietary instruments for preparing and encapsulating fresh tumor biopsies, preserving the tumor microenvironment
- Advanced multimodal microscopy for non-destructive data capture at multiple time points
- Assessment of live biopsy viability, tumor content, and response to immunotherapy
- Secure, centralized data aggregation and analysis
- Cloud-based portal for data access with industry-leading security practices
- Platform designed for placement in pathology labs for predicting efficacy of standard-of-care therapies from core needle biopsies